CAMP4 Therapeutics Corporation

CAMP | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.18

+$0.01 (+0.24%)

Sep 22, 2026, 2:32 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.24%

(1D)

Rating

Updated: Aug 28, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $88.83M

1D Range

3.86 4.22

52W Range

2.50 7.75

Valuation (TTM)

PE -1.87

PB -127.81

EV/EBITDA -0.06

Valuation (NTM)

Forward PE N/A

Forward PEG 0.06

Price Target $10.75

Cash Flow

FCF Yield -32.4%

SBC Adj. FCF Yield -38.7%

SBC Impact -19.3%

Margins

Gross Margin 77.8%

Operating Margin -1242.5%

FCF Margin -681.2%

Growth (CAGR)

Revenue 3Y | 5Y -75.9% | -58.3%

Dil EPS 3Y | 5Y 32.8% | -19.8%

FCF 3Y | 5Y 18.8% | -5.9%

Returns

ROA -114.8%

ROE -314.1%

ROIC -69.8%

Financial Health

Net Cash

$84.03M

Current Ratio 4.70

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and developme...

Sector Healthcare

Industry Biotechnology

Employees 48

IPO Date Oct 10, 2024

Website www.camp4tx.com

Fiscal Year March - February

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10.75

Upside

+157.18%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞